← Evidence map

ReviewClinical cancer research : an official journal of the American Association for Cancer Research2015

Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent.

Nicholas F Dybdal-Hargreaves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

95 papers cite itlatest 60 shown

2015
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25838395